Efficacy of Asparagus recemosus (Satavar) in stimulating follicular growth and ovulation in anovulatory infertility: a randomized controlled trial
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20160362Keywords:
Anovulatory infertility, Asparagus recemosus, Clomiphene citrate, Follicular growth, Ovulation, ConceptionAbstract
Background: Anovulation is the commonest cause of female infertility, responsible for 30% of cases and the most frequent cause of anovulation in women is polycystic ovarian syndrome. The aim of the study was to evaluate the anovulatory efficacy of Asparagus recemosus, commonly known as Satavar, in stimulating follicular growth and ovulation in an ovulatory infertility.
Methods: A randomized standard controlled study was carried out at the National institute of Unani medicine Hospital, Bangalore. Patients (n=40) were randomly allocated to test (n=20) and control (n=20) groups. Infertile women in the age group of 18-40 years with menstrual irregularities, polycystic ovarian disease & spouse normal seminogram were included in the study. Patients with primary ovarian failure, thyroid dysfunction, hyperprolactinaemia, systemic illnesses, malignancy and those on hormonal therapy in last 3 months were excluded. In test group, 6 grams of A. recemosus powder twice daily from day 1-14 of cycle and in control group, clomiphene citrate 50 mg once daily from day 2-6 of cycle was administered orally for 2 consecutive cycles. Primary outcome measures (follicular growth & ovulation) and secondary outcome measure (conception) were assessed for improvement. Data were analyzed using Student ‘t’test, chi-square and Fisher exact test.
Results: After 1st and 2nd cycles of treatment, follicular growth was 30% and 40% in test group and 60% & 50% in control group; ovulatory rate was 25% & 30% in test group and 40% & 25% in control group and conception rate was 0% in test group and 10 % and 5% in control group.
Conclusions: The effect of test drug was comparable with that of control drug in stimulating follicular growth & ovulation, though the drug was not as effective as control drug to achieve conception.
Metrics
References
Branigan FE, Estes MA. A randomized clinical trial of treatment of clomiphene citrate–resistant anovulation with the use of oral contraceptive pill suppression and repeat clomiphene citrate treatment. Am J Obstet Gynecol. 2003;188(6):1424-30.
Legro RS, Brzyski RG, Diamond MP, Coutifaris C, Schlaff WD, Casson P et al. Letrozole versus clomiphene for Infertility in polycystic ovary syndrome. N Engl J Med. 2014;371:119-29.
Berek JS, Adashi EY, Hillared PA. Novak’s Gynaecology. 12th ed. London: Williams and Wilkins;1996:149-68,837-40,915-25,935-41.
Serour GI, Aboulghar M, Al Bahar A, Hugues JN, Esmat K. Phase IV open-label randomized study of low-dose recombinant human follicle-stimulating hormone protocol for ovulation induction. Reproductive Biology and Endocrinology. 2014;12(52):1-9.
Kumar P, Malhotra N. Jefffcoate’s Principles of Gynaecolgy. 7th ed. New Delhi: Jaypee Brothers Medical Publishers (P) Ltd;2008:56-87,101-10,385-96,699-721.
Majoosi ABA. Kamilus Sana (Urdu trans. by Kantoori GH) Vol I & II. New Delhi: Idarae-Kitabul-Shifa;2010:538-40,498-99.
Ibn Sina. Al Qanoon Fil Tib (Urdu trans. by Kantoori GH). New Delhi: Idarae-Kitabul-Shifa;2010:1065-70, 1445-47.
Jurjani AH. Zakheerae Khawarzam Shahi (Urdu trans. by Khan AH). Vol. VI & VIII. New Delhi: Idarae-Kitabul-Shifa; 2010:27-8,606-09.
Khan A. Al Akseer (Urdu trans. by Kabeeruddin). New Delhi: Idarae-Kitabul-Shifa; 2011:819-21.
Razi ABZ. Al HawiFilTib. Vol IX. New Delhi: CCRUM;2001:77-86,90-1,99-100,102-3,106-8,110-1,115-6.
Nagarathna PKM, Rajan PR, Raju Koneri R. A detailed study on polycystic ovarian syndrome and it’s treatment with natural products. Intern J Toxicol Pharmacol Res. 2013-14;5(4):109-20.
Ghani NH. Khazayanul Advia. New Delhi: Idarae-Kitabul-Shifa;2010:788-9.
Sharma K, Bhatnagar M. A. racemosus (Shatavari): a versatile female tonic. Intern J Pharm Biol Arch. 2011;2(3):855-63.
Parihar M, Gada D, Paul PG, Bhowmic S. Letrozole versus clomiphene citrate in Patients with anovulatory infertility. South Asian federation of obstetrics and gynecology. 2009;1(1):19-23.
Ghani NH. Khazayanul Advia. New Delhi: Idarae- Kitabul-Shifa;2010:788-9.
Kabeeruddin M. Makhzanul Mufradat. New Delhi: Idarae-Kitabul-Shifa;2007:250.
Arulkumaran S, Sivanesaratnam V, Chatterjee A, Kumar P. Essentials of Gynaecology. 1st ed. New Delhi: Jaypee Brothers Medical Publishers (P) Ltd; 2005:12-8,205-16,227,231-6.
Berek JS, Adashi EY, Hillared PA. Novak’s Gynaecology. 12th ed. London: Williams and Wilkins;1996:149-68,837-40,915-25,935-41.
Mukherjee GG, Chakravarty S, Pal B, Mukherjee B. Current obstetrics and gynecology. 1st ed. New Delhi: Jaypee Brother’s Medical Publishers (P) Ltd; 2007:232-8.
Balasch J, Fabregues F, Creus M, Puerto B, Penarrubia J, Vanrell JA. Follicular Development and hormone concentrations following recombinant fsh administration for anovulation associated with polycystic ovarian syndrome: Prospective randomized comparison between low-dose step-up and modified step-down regimens. Human Reproduction. 2001;16(4):652-6.
Qayyum B, Chaudhry SM, Sadaf J. Management of anovulatory infertility (polycystic ovary syndrome) with clomiphene alone and in combination with metformin. J Surg Pakistan (International). 2010;15(3):135-8.
Kafeel G, Shameem I, Begum W. Clinical evaluation of Unani formulation in ovulation induction in anovulatory infertility. J AYUSH: Ayurveda, Yoga, Unani, Siddha and Homeopathy. 2013;2(1):25-32.